WELLS FARGO & COMPANY/MN - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$296
-95.7%
230
-95.6%
0.00%
Q2 2023$6,903
+4161.1%
5,230
+2183.8%
0.00%
Q1 2023$162
-6.4%
229
-0.4%
0.00%
Q4 2022$173230
-68.5%
0.00%
Q3 2022$0730
+217.4%
0.00%
Q2 2022$02300.0%0.00%
Q1 2022$02300.0%0.00%
Q4 2021$0
-100.0%
230
-92.9%
0.00%
Q3 2021$8,000
-20.0%
3,2300.0%0.00%
Q2 2021$10,000
-9.1%
3,2300.0%0.00%
Q1 2021$11,000
+1000.0%
3,230
+1304.3%
0.00%
Q4 2020$1,0000.0%2300.0%0.00%
Q3 2020$1,0000.0%230
+0.4%
0.00%
Q2 2020$1,0002290.0%0.00%
Q1 2020$0
-100.0%
2290.0%0.00%
Q4 2019$1,0000.0%2290.0%0.00%
Q3 2019$1,0000.0%2290.0%0.00%
Q2 2019$1,0002290.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2023
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 1,854,278$6,638,0003.61%
Asymmetry Capital Management, L.P. 739,812$2,649,0001.21%
Affinity Asset Advisors, LLC 625,000$2,238,0001.19%
Tri Locum Partners LP 728,710$2,609,0000.95%
Boxer Capital, LLC 6,226,673$22,291,0000.72%
DAFNA Capital Management LLC 668,148$2,392,0000.71%
Vivo Capital, LLC 4,220,938$15,111,0000.67%
Delphi Management Partners VIII, L.L.C. 256,734$919,0000.60%
SILVERARC CAPITAL MANAGEMENT, LLC 280,000$1,002,0000.58%
Rubric Capital Management LP 1,853,417$6,635,0000.49%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders